
明刻·激活:见证非凡,中国替奈普酶开启中国再灌注治疗新时代,引领中国研究走向世界。 过去二十年,中国缺血性脑血管病临床研究实现了从无到有,从起步到引领的跨越式发展。6月14日,首都医科大学附属北...[详细]
明刻·启明:以民族创新破局,以中国方案济世,中国替奈普酶贡献全球卒中救治新方案 过去二十年,中国缺血性脑血管病临床研究实现了从无到有,从起步到引领的跨越式发展。6月14日,首都医科大学附属北京天...[详细]
明刻·求是:实践出真章,多项临床研究和大型真实世界研究,探索中国替奈普酶临床价值。 过去二十年,中国缺血性脑血管病临床研究实现了从无到有,从起步到引领的跨越式发展。6月14日,首都医科大学附属北...[详细]
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- WeRide Inc. (“WeRide” or the “Company”) (Nasdaq: WRD), a global leader in autonomous driving technology, today announced that Dr. Tony Han, Founder, Cha...[详细]
Strategic Collaboration positions Lantronix for long-term opportunities in the global drone market IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader i...[详细]
2026ChinaBio® Partnering Forum 生物医药产业国际合作大会(官网:https://www.cbpfcn.com/,微信公众号: CBPF生物医药产业大会)企业演讲申请全面启动(点击:https://ebdgroup.formstack.com/forms/cbpf_2026 ...[详细]
沙特阿拉伯利雅得, Oct. 28, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) 宣布,将于 2025 年年底启用沙特阿拉伯首个基因和细胞疗法产品生产基地,旨在为成千上万的患者...[详细]
LEIPZIG, Germany and ATLANTA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that...[详细]
对企业而言,线下招商会是打通合作渠道、实现快速盈利的关键场景。但从会前繁杂的筹备工作,到会中紧张的流程执行,再到会后漫长的客户跟踪,每个环节都暗藏 “陷阱”—— 场地选错影响客户体验、客资质量低导致沟通...[详细]
Treo's ROIC process technology leverages high-density, low-power architecture for mission-critical aerospace, defense, security, and scientific applications SCOTTSDALE, Ariz., Oct. 28, 2025 (GLOBE NE...[详细]